explore -WSS

explore

author：fashion 2025-08-12 09:13:02 - browse：763

Pfizer is this year’s anti-Eli Lilly. If David Ricks is the best biopharma CEO of 2023, then Pfizer CEO Albert Bourlais, unfortunately, the worst.

My annual Worst Biopharma CEO list is typically populated with blockheads and scoundrels. That’s not why Bourla is here. The reason is accountability. Strategic missteps, financial miscalculations, and scientific setbacks have plunged Pfizer into a deep crisis. Bourla is the man at the top, so the responsibility lies with him.

Pfizer shares have fallen 50% this year to their lowest level in more than a decade, erasing nearly $140 billion in market value. In 2022, the company delivered $100 billion in revenue, boosted by a widely used Covid vaccine and Covid treatment. This year, Covid product sales evaporated — and will fall further next year — leaving a vacuum Pfizer is struggling to fill with aging medicines nearing the end of their patent lives, and newer drugs and vaccines that have not performed as expected.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Biden announces an advanced cancer research initiative

focus

WSS

Ford recalls 870K F

Behind warning on Apellis’s eye drug lies a conflict of interest

Trump lawyers meet with special counsel in Jan. 6 case as potential indictment looms

Will biotech layoffs continue through 2023?

The mammogram wars are not over

Behind warning on Apellis’s eye drug lies a conflict of interest

focus

explore

leisure time

Hollywood unions extend contract negotiations for actors

Doctors' information doesn't help them choose wisely when sick

New air purifier tech could be key to improving indoor air quality

VC firm RA Capital starts a new synthetic biology incubator

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

BioAge raises $170M for combination therapy with Zepbound

Medical leaders decry Supreme Court decision on affirmative action

The dental labor crisis is a moment of opportunity

Dobbs anniversary: the lost opportunity of abortion as health care

BioAge raises $170M for combination therapy with Zepbound

knowledge

‘We were in the air.’ Mississippi family recounts surviving tornado that tore mobile home apart

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

Trump lawyers meet with special counsel in Jan. 6 case as potential indictment looms

'Revelatory' study finds a smoking impact that remains after quitting

Biden announces an advanced cancer research initiative

Gilead might be held responsible for not developing a drug

entertainment

focus

focus

knowledge